Consistent with these observations, it was reported afterward that IL-17-targeting therapy is not effective in human RA, in contrast to the cases of psoriasis and spondyloarthritis, other chronic inflammatory disorders of the joint [22]. This evidence concerns the gene IL17A and rheumatoid arthritis.